Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-15-3000
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Matrix Metalloproteinase 11 as a Potential Therapeutic Target in Lung Adenocarcinoma

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2019English

EP4 as a Therapeutic Target for Aggressive Human Breast Cancer

2018English

A Novel EML6-ALK FBXO11-ALK Double Fusion Variant in Lung Adenocarcinoma and Response to Crizotinib

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

TBC1D32-RET: A Novel RET Oncogenic Fusion in Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Bombesin Receptor Subtype 3 as a Potential Target for Obesity and Diabetes

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2015English

C-Met as a Potential Therapeutic Target and Biomarker in Cancer

Therapeutic Advances in Medical Oncology
Oncology
2011English

Glycoprotein-130 Expression Is Associated With Aggressive Bladder Cancer and Is a Potential Therapeutic Target

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2006English

PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy